Journal
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Volume 94, Issue 1, Pages 88-96Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09553002.2018.1409443
Keywords
Metformin; glucose deprivation; hypoxia; tumor microenvironment; radiosensitivity
Funding
- Japan Society for the Promotion of Science [26670556, 15H04295]
- Grants-in-Aid for Scientific Research [26670556, 16H06306, 15H04295] Funding Source: KAKEN
Ask authors/readers for more resources
Purpose: In the present study, we investigated whether the disruption of the Hif-1 alpha gene affects the sensitivity of SCC VII cells to metformin and also if metformin functions as a radiosensitizer using murine squamous cell carcinoma (SCC VII) cells. Materials and methods: Cultured SCC VII and SCC VII Hif-1 alpha-deficient cells were incubated with metformin under glucose-free and/or hypoxia-mimetic conditions and cell viabilities were measured. Tumor-bearing mice were continuously given 5-bromo-2'-deoxyuridine (BrdU) to label all proliferating cells. Tumor-bearing mice were then subjected to c-ray irradiation after the metformin treatment. Immediately after irradiation, cells were isolated from some tumors and incubated with a cytokinesis blocker. The responses of quiescent and total (= proliferating + quiescent) cell populations were assessed based on the frequency of micronuclei using immunofluorescence staining for BrdU. Results: The disruption of Hif-1 alpha increased the sensitivity of SCC VII cells to metformin in glucose-free medium. Metformin-induced decreases in the percentage of dead cells in the presence of CoCl2 were partially reduced when Hif-1 alpha was disrupted. In vivo, metformin increased the radiosensitivity of SCC VII Hif-1 alpha-deficient cells. Conclusion: The combination of disruption of Hif-1a and metformin effectively enhanced the radiosensitivity of SCC VII cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available